Carbetapentane and chlorpheniramine and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Carbetapentane and chlorpheniramine and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbetapentane / chlorpheniramine
Brand name: C-Tanna 12, Tannic-12 S, Tussizone-12 RF, Tannate 12 S, Trionate, Tussi-12, Tussi-12S, Tustan 12S
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbetapentane and chlorpheniramine-Insulin degludec
- Carbetapentane and chlorpheniramine-Insulin Degludec (U-100) Prefilled Pens
- Carbetapentane and chlorpheniramine-Insulin Degludec (U-100) Vials
- Carbetapentane and chlorpheniramine-Insulin Degludec (U-200) Prefilled Pens
- Carbetapentane and chlorpheniramine-Insulin degludec and liraglutide
- Carbetapentane and chlorpheniramine-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Carbetapentane and guaifenesin
- Insulin aspart, recombinant Subcutaneous-Carbetapentane and pseudoephedrine
- Insulin aspart, recombinant Subcutaneous-Carbidopa
- Insulin aspart, recombinant Subcutaneous-Carbidopa and levodopa
- Insulin aspart, recombinant Subcutaneous-Carbidopa and levodopa enteral
- Insulin aspart, recombinant Subcutaneous-Carbidopa and Levodopa Enteral Suspension